Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Dairy fat under the microscope: can it calm inflammation?

NCT ID NCT01811329

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how dairy fat, especially a component called milk fat globule membrane, affects inflammation after a high-fat meal. Thirty-eight adults with metabolic syndrome or obesity will consume shakes with different fats, and researchers will measure inflammatory markers in their blood over six hours. The goal is to understand whether dairy fat might reduce the body's inflammatory response to a fatty meal.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dairy fat
What this could lead to
If successful, this could help explain how different types of dietary fat affect inflammation, potentially guiding future dietary recommendations for metabolic health.
What could go wrong
This is a small, early-phase study with only 38 participants, looking at short-term effects over six hours. Results may not apply to long-term health or to the general population.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

38 people

The number who actually took part.

Started

Aug 2013

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-65 years * Two or more components of metabolic syndrome: Central obesity (waist circumference greater than 40 inches for men and 35 inches for women); fasting blood triglycerides greater than or equal to 150 mg/dL; plasma HDL cholesterol (Less than 40 mg/dL for men and less than 50 mg/dL for women); blood pressure greater than or equal to 130/85 mmHg; fasting glucose greater than or equal to 100 mg/dL or \- BMI equal to or greater than 30 Exclusion Criteria: Metabolic Disorders: * BMI \> 40 * Body weight more than 400 lbs. * Any immune related diseases such as autoimmune disease, rheumatoid arthritis, asthma, * Gastrointestinal disorders including Crohn's Disease, colitis, diverticulitis, irritable bowel disease, celiac, malabsorption syndrome * Cancer * Known presence of significant metabolic disease which could impact the results of the study (i.e. hepatic, renal disease) * Type II diabetes * Use of over-the-counter anti-obesity agents (e.g. containing phenylpropanolamine, ephedrine, and/or caffeine) within the last 12 weeks * Use of corticoid steroids within the last 12 weeks * Daily use of anti-inflammatory pain medication * Self report of eating disorder * Poor vein assessment determined by WHNRC's phlebotomist Dietary/supplements: * Known allergy or intolerance to study food (lactose intolerance, dairy, wheat allergies) * Vegetarian (defined as abstinence from consumption of eggs, dairy, poultry, beef and pork) * More than 1 serving of fish per week * More than 14 grams of fiber per 1000 kcal per day * Less than 16:1 of total dietary omega 6: Omega 3 ratio * More than 1% of daily energy as trans fats * Initiation of anti-inflammatory supplemental fish, krill, flax, borage and primrose seed oils within the last 12 weeks * Dietary supplements consisting of concentrated soy isoflavones, resveratrol, other polyphenols identified as modulators of inflammation Medications * Initiation of statin therapy within the last 12 weeks Lifestyle * More than 10% weight loss or gain during the past 6 months * Recent initiation (past 4 weeks) of exercise program * Plan to become pregnant in the next 6 months * Pregnancy or lactation * Recent initiation or cessation of hormonal birth control or change in hormonal birth control regimen within the last 12 weeks * Use of tobacco products * More than 2 standard alcoholic drinks per day.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metabolic syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • USDA Western Human Nutrition Research Center

    Davis, California, 95616, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.